380 related articles for article (PubMed ID: 15945344)
61. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
Jordan K; Kasper C; Schmoll HJ
Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
[TBL] [Abstract][Full Text] [Related]
62. Effectiveness of palonosetron versus other serotonin 5-HT3 receptor antagonists in triple antiemetic regimens during multiday highly emetogenic chemotherapy.
Kim KI; Lee DE; Cho I; Yoon JH; Yoon SS; Lee HS; Oh JM
Ann Pharmacother; 2012 Dec; 46(12):1637-44. PubMed ID: 23170032
[TBL] [Abstract][Full Text] [Related]
63. How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study.
Vanbockstael J; Coquan E; Gouerant S; Allouache D; Faveyrial A; Noal S; Delcambre C; Galais MP; Héron JF; Lefebvre AC; Sevin E; Hrab I; Polycarpe F; André M; Kaluzinski L; Gervais R; Gunzer K; Vié B; Saucier G; Lemenand N; Grellard JM; Clarisse B; Dugué AE; Joly F
Support Care Cancer; 2016 Mar; 24(3):1131-8. PubMed ID: 26268784
[TBL] [Abstract][Full Text] [Related]
64. Chemotherapy-induced nausea and vomiting: an overview and comparison of three consensus guidelines.
Tageja N; Groninger H
Postgrad Med J; 2016 Jan; 92(1083):34-40. PubMed ID: 26561590
[TBL] [Abstract][Full Text] [Related]
65. A dynamic prediction engine to prevent chemotherapy-induced nausea and vomiting.
Mosa ASM; Hossain AM; Yoo I
Artif Intell Med; 2020 Sep; 109():101925. PubMed ID: 34756214
[TBL] [Abstract][Full Text] [Related]
66. [ESMO 2004. Nausea and vomiting caused by chemotherapy: improving the treatment].
Longo F; Mansueto G
Tumori; 2005; 91(1):suppl 36-48. PubMed ID: 15850022
[No Abstract] [Full Text] [Related]
67. Efficacy and safety of electroacupuncture with different acupoints for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial.
Chen B; Hu SX; Liu BH; Zhao TY; Li B; Liu Y; Li MY; Pan XF; Guo YM; Chen ZL; Guo Y
Trials; 2015 May; 16():212. PubMed ID: 25963295
[TBL] [Abstract][Full Text] [Related]
68. Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update.
Patel P; Robinson PD; Phillips R; Baggott C; Devine K; Gibson P; Guilcher GMT; Holdsworth MT; Neumann E; Orsey AD; Spinelli D; Thackray J; van de Wetering M; Cabral S; Sung L; Dupuis LL
Pediatr Blood Cancer; 2023 Aug; 70(8):e30395. PubMed ID: 37178438
[TBL] [Abstract][Full Text] [Related]
69. Implementation of a clinical pharmacist-led service to optimize management of refractory chemotherapy-induced nausea and vomiting in adult hematology/oncology clinic.
Quinn CS; Bergsbaken JJ; Blessinger EJ; Piccolo JK
J Oncol Pharm Pract; 2022 Oct; 28(7):1499-1507. PubMed ID: 34225524
[TBL] [Abstract][Full Text] [Related]
70. Management of chemotherapy-induced nausea and vomiting.
Zubairi IH
Br J Hosp Med (Lond); 2006 Aug; 67(8):410-3. PubMed ID: 16918094
[TBL] [Abstract][Full Text] [Related]
71. Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers.
Van Laar ES; Desai JM; Jatoi A
Support Care Cancer; 2015 Jan; 23(1):151-7. PubMed ID: 25015057
[TBL] [Abstract][Full Text] [Related]
72. Chemotherapy-induced nausea and vomiting (CINV): prevention, detection, and treatment--how are we doing?
ONS News; 2004; 19(9 Suppl):61-2. PubMed ID: 15478591
[TBL] [Abstract][Full Text] [Related]
73. Pediatric oncology provider perspectives and patient/family perceptions of chemotherapy-induced nausea and vomiting management: Experiences at an academic medical center.
Bloomhardt H; Rubin M; Xue Y; Jin Z; Masino L; Seidel D; Hijiya N; Beauchemin M
Pediatr Blood Cancer; 2024 Apr; 71(4):e30883. PubMed ID: 38279826
[TBL] [Abstract][Full Text] [Related]
74. Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study.
Grassi L; Berardi MA; Ruffilli F; Meggiolaro E; Andritsch E; Sirgo A; Caruso R; Juan Linares E; Bellé M; Massarenti S; Nanni MG;
Psychother Psychosom; 2015; 84(6):339-47. PubMed ID: 26402426
[TBL] [Abstract][Full Text] [Related]
75. Unscheduled hydrations: redefining complete response in chemotherapy-induced nausea and vomiting studies.
Navari RM; Roeland EJ
Future Oncol; 2020 Aug; 16(24):1863-1872. PubMed ID: 32543309
[TBL] [Abstract][Full Text] [Related]
76. Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies.
Adel N
Am J Manag Care; 2017 Sep; 23(14 Suppl):S259-S265. PubMed ID: 28978206
[TBL] [Abstract][Full Text] [Related]
77. Demystifying CINV control in the complex aging patient: assessing the complexities of the aging oncology patient.
ONS News; 2004; 19(9 Suppl):5-8. PubMed ID: 15478565
[TBL] [Abstract][Full Text] [Related]
78. Ginger-Mechanism of action in chemotherapy-induced nausea and vomiting: A review.
Marx W; Ried K; McCarthy AL; Vitetta L; Sali A; McKavanagh D; Isenring L
Crit Rev Food Sci Nutr; 2017 Jan; 57(1):141-146. PubMed ID: 25848702
[TBL] [Abstract][Full Text] [Related]
79. What occurs in the other 20% of cancer patients with chemotherapy-induced nausea and vomiting (CINV)? A single-institution qualitative study.
Childs DS; Looker S; Le-Rademacher J; Ridgeway JL; Breitkopf CR; Jatoi A
Support Care Cancer; 2019 Jan; 27(1):249-255. PubMed ID: 29938306
[TBL] [Abstract][Full Text] [Related]
80. The Effectiveness of Hologram Bracelets in Reducing Chemotherapy-Induced Nausea and Vomiting Among Adult Patients With Cancer.
Akhu-Zaheya LM; Khater WA; Lafi AY
Cancer Nurs; 2017; 40(2):E17-E29. PubMed ID: 27088609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
